Stay updated on NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial
Sign up to get notified when there's something new on the NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial page.

Latest updates to the NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial page
- Check4 days agoChange DetectedThe completed phase 3 trial record is now displayed, including its design, eligibility criteria, treatment arms, outcome findings, locations, and study documents. The prior access-denied error and Home link are no longer shown.SummaryDifference68%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check25 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1. The study page still shows a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision indicator changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden message with the page header and a Home link, and shows a revision tag (Revision: v3.7.0). Some study-item content previously listed appears to have been removed.SummaryDifference19%

Stay in the know with updates to NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NAC vs Ambroxol vs Placebo in Respiratory Patients Clinical Trial page.